ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe - FRA:ABL - US0028241000 - Common Stock
112.54 EUR
+0.02 (+0.02%)
We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 59 industry peers in the Health Care Equipment & Supplies industry. ABL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, ABL is valued expensive at the moment. These ratings would make ABL suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year ABL was profitable.
In the past year ABL had a positive cash flow from operations.
In the past 5 years ABL has always been profitable.
In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
ABL's Return On Assets of 16.64% is amongst the best of the industry. ABL outperforms 91.53% of its industry peers.
Looking at the Return On Equity, with a value of 27.65%, ABL belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.37%, ABL is doing good in the industry, outperforming 79.66% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 8.90%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| ROIC | 9.37% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
ABL has a Profit Margin of 32.43%. This is amongst the best in the industry. ABL outperforms 98.31% of its industry peers.
ABL's Profit Margin has improved in the last couple of years.
ABL has a better Operating Margin (17.85%) than 79.66% of its industry peers.
In the last couple of years the Operating Margin of ABL has grown nicely.
ABL has a Gross Margin (56.20%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.85% | ||
| PM (TTM) | 32.43% | ||
| GM | 56.2% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABL is still creating some value.
Compared to 1 year ago, ABL has about the same amount of shares outstanding.
The number of shares outstanding for ABL has been reduced compared to 5 years ago.
ABL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.94 indicates that ABL is not in any danger for bankruptcy at the moment.
The Altman-Z score of ABL (5.94) is better than 91.53% of its industry peers.
ABL has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
ABL has a better Debt to FCF ratio (1.98) than 81.36% of its industry peers.
ABL has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ABL (0.26) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.98 | ||
| Altman-Z | 5.94 |
ROIC/WACC1.12
WACC8.35%
2.3 Liquidity
A Current Ratio of 1.82 indicates that ABL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.82, ABL is in line with its industry, outperforming 54.24% of the companies in the same industry.
A Quick Ratio of 1.30 indicates that ABL should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.30, ABL is doing good in the industry, outperforming 64.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.11%, which is quite good.
The Earnings Per Share has been growing slightly by 7.59% on average over the past years.
The Revenue has been growing slightly by 5.85% in the past year.
ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.63% yearly.
EPS 1Y (TTM)10.11%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%10.53%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.37%
3.2 Future
Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.87% on average per year.
ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.13% yearly.
EPS Next Y11.28%
EPS Next 2Y10.75%
EPS Next 3Y10.76%
EPS Next 5Y9.87%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.23%
Revenue Next 5Y7.13%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.12, ABL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 66.10% of the companies listed in the same industry.
ABL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.22, which indicates a rather expensive current valuation of ABL.
The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
ABL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.12 | ||
| Fwd PE | 23.22 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 67.80% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.17 | ||
| EV/EBITDA | 21.9 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)2.4
PEG (5Y)3.57
EPS Next 2Y10.75%
EPS Next 3Y10.76%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.78%, ABL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.30, ABL pays a bit more dividend than its industry peers.
ABL's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
5.2 History
On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.42% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.42%
EPS Next 2Y10.75%
EPS Next 3Y10.76%
FRA:ABL (9/18/2025, 7:00:00 PM)
112.54
+0.02 (+0.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners80.67%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap195.87B
Analysts78.86
Price Target123.37 (9.62%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
Yearly Dividend1.89
Dividend Growth(5Y)11.4%
DP28.42%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.08%
Min EPS beat(2)-0.58%
Max EPS beat(2)0.73%
EPS beat(4)1
Avg EPS beat(4)-0.34%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)8.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.19%
Revenue beat(8)1
Avg Revenue beat(8)-0.29%
Revenue beat(12)5
Avg Revenue beat(12)0.8%
Revenue beat(16)9
Avg Revenue beat(16)2.75%
PT rev (1m)-0.86%
PT rev (3m)-2.31%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)-2.98%
EPS NY rev (1m)-0.3%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.12 | ||
| Fwd PE | 23.22 | ||
| P/S | 5.37 | ||
| P/FCF | 34.17 | ||
| P/OCF | 25.61 | ||
| P/B | 4.58 | ||
| P/tB | 11.19 | ||
| EV/EBITDA | 21.9 |
EPS(TTM)4.15
EY3.69%
EPS(NY)4.85
Fwd EY4.31%
FCF(TTM)3.29
FCFY2.93%
OCF(TTM)4.39
OCFY3.9%
SpS20.96
BVpS24.58
TBVpS10.06
PEG (NY)2.4
PEG (5Y)3.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| ROCE | 10.91% | ||
| ROIC | 9.37% | ||
| ROICexc | 10.45% | ||
| ROICexgc | 19.79% | ||
| OM | 17.85% | ||
| PM (TTM) | 32.43% | ||
| GM | 56.2% | ||
| FCFM | 15.72% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexcg growth 3Y-24.08%
ROICexcg growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.98 | ||
| Debt/EBITDA | 1.19 | ||
| Cap/Depr | 72.02% | ||
| Cap/Sales | 5.25% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.38% | ||
| Profit Quality | 48.47% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 5.94 |
F-Score7
WACC8.35%
ROIC/WACC1.12
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.11%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%10.53%
EPS Next Y11.28%
EPS Next 2Y10.75%
EPS Next 3Y10.76%
EPS Next 5Y9.87%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.37%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.23%
Revenue Next 5Y7.13%
EBIT growth 1Y13.84%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.75%
EBIT Next 3Y15.65%
EBIT Next 5Y12.28%
FCF growth 1Y23.45%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y21.27%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%